CompaniesNanogen Pharmaceutical Biotechnology

Nanogen Pharmaceutical Biotechnology

active
Ho Chi Minh City, Vietnam
Founded 1993
Website
About

Biosimilars

Areas of Focus

Categories

BiosimilarsAsia
Clinical Trials (11)
View all

Total Trials

11

As Lead Sponsor

11

As Collaborator

0

Total Enrollment

14,417

By Phase

PHASE1: 5PHASE3: 4PHASE1/PHASE2: 1PHASE4: 1

By Status

COMPLETED: 9NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02063607
NCT05301010
NCT05585645
Hover over trial bars to see details

Recent Trials

NCT06919861Lead Sponsor
Pharmacokinetics, Pharmacodynamics, and Safety of Nanokine Produced by Nanogen Pharmaceutical Joint Stock Company
PHASE1Not yet recruiting
44 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2025
NCT05636891Lead Sponsor
Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis
PHASE1Completed
43 participants
Started: Sep 19, 2021 · Completed: Nov 23, 2022
NCT04922788Lead Sponsor
Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19
PHASE3Completed
13,006 participants
Started: Jun 7, 2021 · Completed: Jul 20, 2022
NCT04683484Lead Sponsor
A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers
PHASE1/PHASE2Unknown
620 participants
Started: Dec 10, 2020 · Completed: Aug 10, 2021
NCT05585645Lead Sponsor
A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)
PHASE3Completed
214 participants
Started: Aug 8, 2019 · Completed: Nov 23, 2022
View all 11 trials →
Locations (1)
Headquarters
Ho Chi Minh City, Vietnam
Map

Loading map...